TCL Archive Cancer clinical trials cooperative groups are in jeopardy, and changes are needed to enable the system to survive, chairmen of the groups wrote in a paper submitted to NCI. White paper makes 25 recommendations, including changing system incentives, review process, group integration with centers and SPOREs, and inclusion in CaBIG. This 8-page issue includes full text of the white paper. April 2, 2004
TCL Archive Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer October 6, 1989
TCL Archive Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item May 2, 1980
TCL Archive FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma. February 17, 2006
